Therapy-related MDS dissected based on primary disease and treatment—a nationwide perspective

por Moreno Berggren, Daniel, Garelius, Hege, Willner Hjelm, Petter, Nilsson, Lars, Rasmussen, Bengt, Weibull, Caroline E., Lambe, Mats, Lehmann, Sören, Hellström-Lindberg, Eva, Jädersten, Martin, Ejerblad, Elisabeth
Publicado 2023

“Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”

por Rasmussen, Bengt, Göhring, Gudrun, Bernard, Elsa, Nilsson, Lars, Tobiasson, Magnus, Jädersten, Martin, Garelius, Hege, Dybedal, Ingunn, Grønbaek, Kirsten, Ejerblad, Elisabeth, Lorenz, Fryderyk, Flogegård, Max, Marcher, Claus Werenberg, Öster Fernström, Annette, Cavelier, Lucia, Papaemmanuil, Elli, Ebeling, Freja, Kittang, Astrid Olsnes, Nørgaard, Jan Maxwell, Saft, Leonie, Möllgård, Lars, Hellström-Lindberg, Eva
Publicado 2022